FR3111542B1 - Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique - Google Patents

Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique Download PDF

Info

Publication number
FR3111542B1
FR3111542B1 FR2006476A FR2006476A FR3111542B1 FR 3111542 B1 FR3111542 B1 FR 3111542B1 FR 2006476 A FR2006476 A FR 2006476A FR 2006476 A FR2006476 A FR 2006476A FR 3111542 B1 FR3111542 B1 FR 3111542B1
Authority
FR
France
Prior art keywords
aqueous extract
lavender
antifungal
antibacterial
usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2006476A
Other languages
English (en)
Other versions
FR3111542A1 (fr
Inventor
Bruno Eto
Salima Boutahiri
Sevser Sahpaz
Jennifer Samaillie
Touriya Zair
Bernard Gressier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR2006476A priority Critical patent/FR3111542B1/fr
Publication of FR3111542A1 publication Critical patent/FR3111542A1/fr
Application granted granted Critical
Publication of FR3111542B1 publication Critical patent/FR3111542B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Composition pharmaceutique ou diététique contenant de l’extrait aqueux de lavande et utilisable comme antibactérien et antifongique. Selon l'invention, cette composition peut en outre comprendre un extrait aqueux d'au moins une deuxième plante parmi les plantes suivantes : Punica granatum L, Rosmarinus officinalis L, Salvia officinalis L, Origanum compactum, Origanum majorana.
FR2006476A 2020-06-21 2020-06-21 Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique Active FR3111542B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2006476A FR3111542B1 (fr) 2020-06-21 2020-06-21 Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2006476A FR3111542B1 (fr) 2020-06-21 2020-06-21 Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique
FR2006476 2020-06-21

Publications (2)

Publication Number Publication Date
FR3111542A1 FR3111542A1 (fr) 2021-12-24
FR3111542B1 true FR3111542B1 (fr) 2023-01-13

Family

ID=72644394

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2006476A Active FR3111542B1 (fr) 2020-06-21 2020-06-21 Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique

Country Status (1)

Country Link
FR (1) FR3111542B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2950808B1 (fr) * 2009-10-02 2011-11-18 Titis Business Corp Tbc Composition pharmaceutique ou dietetique pour inhiber la contraction des muscles lisses
EP3035946A1 (fr) * 2013-08-20 2016-06-29 SWM Luxembourg s.a.r.l. Produit comprenant une plante pour un usage médicinal, cosmétique, de coloration ou dermatologique
FR3072567A1 (fr) * 2017-10-19 2019-04-26 Bruno Eto Composition pharmaceutique ou dietetique contenant de l’extrait d’origanum majorana et utilisable pour reguler le cycle enterosystemique intestinal de l’eau.
FR3077732B1 (fr) * 2018-02-15 2020-11-13 Robertet Procede d’obtention d’un extrait enrichi en acide rosmarinique a partir de matiere vegetale fraiche
CN110373395B (zh) * 2019-06-05 2021-03-26 中国农业科学院北京畜牧兽医研究所 提高漆酶对真菌毒素降解率的薰衣草介体及其应用

Also Published As

Publication number Publication date
FR3111542A1 (fr) 2021-12-24

Similar Documents

Publication Publication Date Title
Hussein et al. Evaluation of cytotoxicity, biochemical profile and yield components of groundnut plants treated with nano-selenium
Becker et al. Bioactivity guided isolation of antimicrobial compounds from Lythrum salicaria
Özçelik et al. Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera
BR0009430A (pt) Cepa do bacilo pumilus para controle de doenças de plantas
Khan et al. In vitro antibacterial, antifungal and GC-MS analysis of seeds of Mustard Brown
Egamberdieva et al. Medicinal plants and PGPR: a new frontier for phytochemicals
Moradi et al. Quorum-quenching activity of some Iranian medicinal plants
YILMAZ et al. Comparison of the antimicrobial activity of some Scutellaria orientalis L. taxa growing in Turkey
FR3111542B1 (fr) Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique
MA51927A1 (fr) Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique
Manoorkar et al. Antifungal activity of leaf and latex extracts of Calotropis procera (Ait.) against dominant seed-borne storage fungi of some oil seeds
Lukošiūtė et al. The effect of Lamiaceae plants essential oils on fungal plant pathogens in vitro
Shanayda et al. Antimicrobial activity of essential oils of plants belonging to Lamiaceae Juss. family
Behravan et al. Antimycotic activity of the essential oil of Satureja mutica Fisch & CA Mey from Iran
Awaad et al. Phytochemical analysis and antimicrobial activity of medicinal plants against pathogenic microorganisms
Najjaa et al. Antimicrobial activities of protenic extracts of Allium roseum L., a wild edible species in North Africa
Kačániová et al. In vitro antimicrobial activity of four Slovak medicinal plants against different strains of bacteria
Al-Judaibi et al. Antifungal effect of ethanol plant extract on Candida sp
EL-HABBAA et al. In vitro evaluation of some fungicides, commercial biocontrol formulations and natural plant extracts on peanut root-rot pathogens
Musheer et al. Potential of Plant Growth-Promoting Microbes in Disease Reduction by Influencing the Antioxidant Enzymes of Medicinal and Spice Plants
BR0203466A (pt) Extrato de um isolado de bactéria da pele, método para tratamento, isolado bacteriano, métodos de identificar metabólitos bacterianos, extratos, frações ou compostos biologicamente, extrato, fração ou composto biologicamente ativo, composição farmacêutica, e, métodos de inibir o crescimento de organismos patogênicos em um indivìduo, de células tumorais em um indivìduo, e de um vìrus em um indivìduo
Ćirić et al. Recent Advances in Science of Quorum Sensing: An Overview of Natural Product Inhibitors
Kannan Chapter-8 biological management of plant diseases
Castro et al. Antimicrobial activity of biogenic hop-based silver nanoparticles for application in sugar and alcohol industries
Rahanandeh et al. The inhibitory effect of five plant extracts on the pathogen of mulberry dieback disease (Sclorotinia sclerotiorum) in laboratory conditions

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLSC Publication of the preliminary search report

Effective date: 20211224

PLFP Fee payment

Year of fee payment: 4